Riegg, F.;                     Lutz, M.S.;                     Schmied, B.J.;                     Heitmann, J.S.;                     Queudeville, M.;                     Lang, P.;                     Jung, G.;                     Salih, H.R.;                     Märklin, M.    
        An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia. Cancers 2021, 13, 1632.
    https://doi.org/10.3390/cancers13071632
    AMA Style
    
                                Riegg F,                                 Lutz MS,                                 Schmied BJ,                                 Heitmann JS,                                 Queudeville M,                                 Lang P,                                 Jung G,                                 Salih HR,                                 Märklin M.        
                An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia. Cancers. 2021; 13(7):1632.
        https://doi.org/10.3390/cancers13071632
    
    Chicago/Turabian Style
    
                                Riegg, Fabian,                                 Martina S. Lutz,                                 Bastian J. Schmied,                                 Jonas S. Heitmann,                                 Manon Queudeville,                                 Peter Lang,                                 Gundram Jung,                                 Helmut R. Salih,                                 and Melanie Märklin.        
                2021. "An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia" Cancers 13, no. 7: 1632.
        https://doi.org/10.3390/cancers13071632
    
    APA Style
    
                                Riegg, F.,                                 Lutz, M. S.,                                 Schmied, B. J.,                                 Heitmann, J. S.,                                 Queudeville, M.,                                 Lang, P.,                                 Jung, G.,                                 Salih, H. R.,                                 & Märklin, M.        
        
        (2021). An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia. Cancers, 13(7), 1632.
        https://doi.org/10.3390/cancers13071632